KH801

· Beijing Kanghong Biopharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for KH801, covering 2024-08-07 to 2024-08-07. Get the full timeline:

Most recent: Clinical Trial Update: Phase 1 Trial of KH801 [Phase 1]